Rare Cancer Atlas
While all cancer diagnoses raise concerns and difficult questions for patients, their families, and their health care providers, rare cancers present additional challenges. Access to tumors and relevant samples for study is more limited, and commercial interest is lower because of decreased market size. The Bertarelli Rare Cancer Initiative supports advances in the detection, diagnosis, treatment, and prevention of rare cancers. Our vision is to build a world-class, highly interactive and collaborative hub for rare cancer research, clinical care advancement, advocacy and training, building upon the extensive and vibrant clinical and research communities across Harvard Medical School. Our long-term goal is to become an innovative world-wide initiative.
Narrated Minerva Stories
Narrated stories use multi-step narrations and annotations to walk a viewer through key features of the data. Narrated stories distill the multidisciplinary knowledge encompassed by each dataset into a single product that grounds the scientific analyses in the underlying data and metadata. Click the Minerva story icon for an interactive view of the full-resolution images.
Funding
Research on rare cancers is supported by the The Bertarelli Rare Cancer Initiative.